Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
US8637469B2 · kind B2 · utility
13Cited by
2References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 11, 2007 |
| Grant date | Jan 28, 2014 |
| Priority date | — |
| Expiry date | Jun 16, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention describes a method of treating upper airway disease by administering a composition of one or more proinflammatory cytokine inhibitors sufficient to inhibit inflammation in the upper airways. The proinflammatory cytokines that are inhibited include TNF, IL-1 and IL-8. A medication dispensing unit which includes a container and a delivery system is used to administer the composition. The delivery system further encompasses a one-way valve, a microcatheter, or a liquid-pressure type sprayer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.